This inventor holds 2 USPTO granted patents. Top assignees: Kabi Pharmacia Ab, Pharmacia Ab. Active years: 1978-1993.
Company Filing History:
Years Active: 1978-1993
Title: Kurt Hedegaard: Innovator in Bronchospasmolytic Compounds
Introduction
Kurt Hedegaard is a notable inventor based in Horsholm, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of compounds with bronchosposmolytic activity. With a total of 2 patents to his name, Hedegaard's work has had a meaningful impact on medical science.
Latest Patents
Hedegaard's latest patents focus on a product designed for use in occlusive epicutaneous testing. This product is aimed at addressing bronchospasmolytic phenylethanolamines, specifically those of the formula I, where various substitutions can be made to the phenyl or other groups. The compounds he has developed possess bronchosposmolytic activity, showcasing his innovative approach to pharmacological challenges.
Career Highlights
Throughout his career, Kurt Hedegaard has worked with prominent companies in the pharmaceutical industry, including Kabi Pharmacia AB and Pharmacia AB. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in drug development.
Collaborations
Hedegaard has collaborated with notable colleagues such as Sten Albrectsen and Jens Hansen. These partnerships have likely enriched his research and development efforts, leading to innovative solutions in the field.
Conclusion
Kurt Hedegaard's contributions to the field of pharmacology, particularly through his patents and collaborations, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.